Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China
· Delayed Price · Currency is CNY 18.42
-0.39 (-2.07%)
Apr 29, 2026, 2:15 PM CST
SHE:000739 Revenue
Apeloa Pharmaceutical Co.,Ltd had revenue of 2.45B CNY in the quarter ending March 31, 2026, a decrease of -10.36%. This brings the company's revenue in the last twelve months to 9.50B, down -17.77% year-over-year. In the year 2025, Apeloa Pharmaceutical Co.,Ltd had annual revenue of 9.78B, down -18.62%.
Revenue (ttm)
9.50B
Revenue Growth
-17.77%
P/S Ratio
2.23
Revenue / Employee
1.40M
Employees
6,787
Market Cap
21.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.78B | -2.24B | -18.62% |
| Dec 31, 2024 | 12.02B | 547.70M | 4.77% |
| Dec 31, 2023 | 11.47B | 929.26M | 8.81% |
| Jan 1, 2023 | 10.54B | 1.60B | 17.92% |
| Jan 1, 2022 | 8.94B | 1.06B | 13.49% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Betta Pharmaceuticals | 3.73B |
| Jilin Aodong Pharmaceutical Group | 2.34B |
| Walvax Biotechnology | 2.40B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 1.17B |
| Chengdu Kanghong Pharmaceutical Group | 4.43B |
| Tasly Pharmaceutical Group | 8.35B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.01B |
| Hybio Pharmaceutical | 898.10M |